Nonmigraine Headache and Facial Pain: Overview & Expert Interview
Accurate diagnosis is essential to inform treatment strategy, particularly with headaches that may be secondary to a potentially life-threatening medical condition.
Pain
Neuropathic Pain in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
For patients with chronic inflammatory demyelinating polyradiculoneuropathy, the presence of neuropathic pain leads to worsened disability and disease outcome.
Novel vs Traditional Spinal Cord Stimulation Therapies for Chronic Low Back Pain
The use of novel waveforms, frequencies, and stimulation modes in spinal cord stimulation (SCS) therapies may be more effective at relieving chronic low back pain and/or leg pain compared with traditional tonic low-frequency SCS.
Stimulating Dorsal Root Ganglions Plus Dorsal Columns for Complex Pain Patterns
For certain patients with complex pain patterns, stimulating both dorsal root ganglion and dorsal columns may relieve pain effectively.
Mirogabalin May Alleviate Pain Associated With Postherpetic Neuralgia
Mirogabalin was found to be safe, well tolerated, and effective at alleviating postherpetic neuralgia-associated pain.
Direct-to-Doctor Payments May Increase Opioid Prescribing
Physicians who receive direct pharmaceutical payments for opioid prescribing prescribe more opioids, especially hydrocodone and oxycodone.
Mindfulness-Based Stress Reduction Also Benefits Chronic Pain
For patients with chronic pain (CP), both mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT) improve physical functioning, pain intensity, and depression.
CDC: Opioid Prescribing Higher in Rural Versus Urban Areas
The percentage of individuals prescribed an opioid is higher in rural than urban areas.
FDA Approves Two New Strengths of Apadaz for Pain Management
Apadaz was initially approved in February 2018 as 6.12mg/325mg immediate-release tablets for the short-term (no more than 14 days) management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Kinesiophobia May Be Associated With Greater Cutaneous Allodynia in Migraine
Approximately half of patients with migraine have kinesiophobia, and the condition is associated with greater severity, not presence of cutaneous allodynia.
Next post in Migraine and Headache
